Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
10/09/1990 | US4961927 Clear solution containing lysozyme hydrochloride and dipotassium glycyrrhizinate |
10/09/1990 | US4961926 Methods for prevention and treatment of mucositis with granulocyte colony stimulating factor |
10/09/1990 | CA1275062A1 Plasminogen activator kym |
10/09/1990 | CA1275044A1 Method of passive immunization of mammals using avian and/or bovid antibody and compositions for same |
10/08/1990 | CA2051676A1 Urokinase-type plasminogen activator receptor |
10/08/1990 | CA2014006A1 Monoclonal antibodies to tetracyclic compounds, processes for their production, and applications |
10/07/1990 | CA2014103A1 Interleukin-1 formulation |
10/07/1990 | CA2014051A1 Inhibition of mineral deposition by phosphorylated and related polyanionic peptides |
10/07/1990 | CA2014009A1 Urokinase precursor-stabilizing method and dried composition |
10/07/1990 | CA2013909A1 Antibacterial preparation and method using polypeptide obtainable from royal jelly |
10/06/1990 | WO1990011782A2 Immunoconjugates and prodrugs and their use in association for drug delivery |
10/06/1990 | CA2030564A1 Immunoconjugates and prodrugs and their use in association for drug delivery |
10/06/1990 | CA2013941A1 Process for preparing a therapeutic agent for rotavirus infection |
10/05/1990 | WO1990012097A1 Recombinant trichosanthin and coding sequence |
10/05/1990 | CA2050593A1 Recombinant trichosanthin and coding sequence |
10/05/1990 | CA2013801A1 Synergistic compositions containing ketanserin |
10/05/1990 | CA2012901A1 Amino acid derivatives |
10/05/1990 | CA2010835A1 Antibody purification process |
10/04/1990 | WO1990012108A1 Megakaryocyte growth promoting activity |
10/04/1990 | WO1990012101A1 Vaccinia vectors, vaccinia genes and expression products thereof |
10/04/1990 | WO1990011783A1 Platelet specific immunoconjugates |
10/04/1990 | WO1990011773A1 Method and means for inducing, resp., preventing constriction of the pupil in the eye |
10/04/1990 | WO1990011696A1 Reducing post-prandial plasma large neutral amino acid concentrations |
10/04/1990 | WO1990011365A1 Dna sequence encoding a lymphocyte adhesion receptor for high endothelium |
10/04/1990 | WO1990011360A1 POLYPEPTIDE RESULTING FROM THE FUSION BETWEEN A MALTOSE-RELATED COMPOUND (MalE) AND A CD4 FRAGMENT FOR NEUTRALIZING THE AIDS VIRUS |
10/04/1990 | WO1990011359A1 Intracellular method of inhibiting hiv in mammalian cells |
10/04/1990 | WO1990011358A1 Method for detection and/or identification of lyssavirus infections, cloning and expression of genes coding for peptides and/or fragments of peptides of mokola lyssavirus, vaccine against the mokola virus and/or the family of lyssaviruses as well as method for obtaining said vaccine via genetic engineering |
10/04/1990 | WO1990011354A1 Process for the specific replacement of a copy of a gene present in the receiver genome via the integration of a gene |
10/04/1990 | WO1990011353A1 Recombinant alpha-galactosidase, a therapy for fabry disease |
10/04/1990 | WO1990011302A1 Antibody and t cell recognition sites on glycoproteins |
10/04/1990 | WO1990011300A1 New substituted alkylamide derivatives of teicoplanin |
10/04/1990 | WO1990011296A1 Insulinotropic hormone |
10/04/1990 | WO1990011293A1 Allergenic proteins from ragweed and uses therefor |
10/04/1990 | WO1990011292A2 Controlled-action anesthetic compounds and pharmaceutical compositions containing same |
10/04/1990 | WO1990011289A1 Improvements relating to the radio-labelling of proteins |
10/04/1990 | WO1990011287A1 Matrix metalloproteinase inhibitor peptides |
10/04/1990 | WO1990011092A1 Expression of exogenous polynucleotide sequences in a vertebrate |
10/04/1990 | WO1990011090A1 Pharmaceutical compositions |
10/04/1990 | WO1990011084A1 Endothelial cell growth factor, isolation and expression |
10/04/1990 | WO1990011083A1 Use of interleukin 2 to treat endotoxinemia |
10/04/1990 | WO1990011075A1 Angiogenic monobutyrin and its analogs |
10/04/1990 | WO1990011071A1 Angiogenic butyric acid analogs and their prodrugs |
10/04/1990 | WO1990011070A1 Controlled release delivery device for macromolecular proteins |
10/04/1990 | WO1990011024A1 Nutritious composition |
10/04/1990 | DE3910011A1 Verwendung von interleukin-2 bei ausgedehnten bakteriellen infektionen The use of interleukin-2 for extended bacterial infections |
10/04/1990 | CA2489769A1 Expression of exogenous polynucleotide sequences in a vertebrate |
10/04/1990 | CA2357538A1 Expression of exogenous polynucleotide sequences in a vertebrate |
10/04/1990 | CA2051436A1 Platelet specific immunoconjugates |
10/04/1990 | CA2050585A1 Reducing post-prandial plasma large neutral amino acid concentrations |
10/04/1990 | CA2050584A1 Megakaryocyte growth promoting activity |
10/04/1990 | CA2033200A1 Vaccinia vectors, vaccinia genes and expression products thereof |
10/04/1990 | CA2030525A1 Method and means for inducing, resp., preventing constriction of the pupil in the eye |
10/04/1990 | CA2013475A1 Amino acid derivatives |
10/03/1990 | EP0390602A1 Neurotrophic peptides |
10/03/1990 | EP0390323A2 Detection of loss of the wild-type p53 gene |
10/03/1990 | EP0390252A2 Purification of recombinant human interleukin-3 |
10/03/1990 | EP0390071A1 Preservative system for ophthalmic formulations |
10/03/1990 | EP0390067A1 PP4-delta, preparation and use thereof |
10/03/1990 | EP0390040A1 Ribosome inactivating proteins and derivatives thereof |
10/03/1990 | EP0390039A2 N-Acyl derivatives of the peptidoglycan monomer, pharmaceutically acceptable salts thereof, their preparation and use in the manufacture of immunomodulators and immunoadjuvants |
10/03/1990 | EP0389983A2 Monoclonal antibodies to preS2 and preS1 polypeptides of the hepatitis B viral envelope |
10/03/1990 | EP0389950A1 Melanocyte-stimulating hormone inhibitor and external preparation containing the same |
10/03/1990 | EP0389898A2 Peptide derivatives of amino acids having a renin-inhibiting effect |
10/03/1990 | EP0389795A1 Bioactive lactoferrin derivates |
10/03/1990 | EP0389590A1 Milk constituents, process for producing them and agents containing them |
10/03/1990 | EP0389554A1 Immunoreactive heterochain antibodies |
10/03/1990 | EP0389535A1 Renin inhibitors, processes for preparing them, methods for using them, and compositions containing them |
10/03/1990 | EP0236163B1 Derivatives of n-alpha-substituted n-alpha-arylsulfonylaminoacyl p-amidinophenylalaninamides, their preparation, their use as medicaments and their intermediates |
10/03/1990 | CN1045793A Novel insulin compounds and process for preparing same |
10/03/1990 | CA2013457A1 Bifunctional protein designated idf 45 |
10/03/1990 | CA2013276A1 0 -alkyl derivatives of aglycone and pseudoaglycones of teicoplanin |
10/03/1990 | CA2013133A1 Pharmaceutical composition |
10/02/1990 | US4960792 Hypotensive agents |
10/02/1990 | US4960757 Pasteurized human fibrinogen (HF), a process for its preparation, and its use |
10/02/1990 | US4960756 Lectin like protein substance, method of obtaining same and anti-tumor agent comprising same |
10/02/1990 | US4960700 Compositions and methods for the synthesis and assay of a mammalian enkephalinase |
10/02/1990 | US4960591 Non-fat dry milk, sodium bicarbonate and yeast; side effect reduction |
10/02/1990 | CA1274774A1 Method for administering insulin |
10/01/1990 | WO1990012034A1 Ribozome inactivating proteins and derivatives thereof |
10/01/1990 | WO1990011780A1 Preparation of liposome and lipid complex compositions |
10/01/1990 | CA2050592A1 Ribosome inactivating proteins and derivatives thereof |
10/01/1990 | CA2049301A1 Method for treating respiratory distress syndrome |
10/01/1990 | CA2013443A1 Pharmaceutical compositions and their use in the treatment of parasitoses |
09/30/1990 | CA2013517A1 Monoclonal antibodies to pres2 and pres1 polypeptides of the hepatitis b viral envelope |
09/30/1990 | CA2013403A1 Pp4-delta, the preparation and use thereof |
09/30/1990 | CA2013300A1 Neurotrophic peptides |
09/29/1990 | WO1990011366A1 Osteoinductive compositions |
09/28/1990 | CA2012306A1 Amino acid derivatives |
09/27/1990 | DE3909600A1 Use of cycloalkano[1,2-b]indolesulphonamides in combination with plasminogen activators as drugs in thrombolytic therapy |
09/27/1990 | CA2013065A1 N-acyl derivatives of the peptidoglycan monomer, pharmaceutically acceptable salts thereof, their preparation and use in the manufacture of immunomodulators and immunoadjuvants |
09/26/1990 | EP0389180A1 Peptides and their use in therapy |
09/26/1990 | EP0389127A1 Renin-inhibitory di-, tri-, and tetrapeptides |
09/26/1990 | EP0389043A1 Production of modified PE40 |
09/26/1990 | EP0388914A1 Monoclonal antibodies against tumor associated antigen, their preparation and use |
09/26/1990 | EP0388906A2 Genetically engineered human cholinesterases |
09/26/1990 | EP0388799A2 Use of human interferon-beta for stimulation of erythropoieses |
09/26/1990 | EP0388758A1 Protein-polycation conjugate |
09/26/1990 | EP0388510A1 Pharmaceutical compositions and their use in the prophylaxis or the treatment of bacterial infectious diseases |
09/26/1990 | EP0388434A1 Differential delivery of therapeutic agents across the blood brain barrier |
09/26/1990 | EP0374188A4 Dietary supplement utilizing omega-3/medium chain triglyceride mixtures |